Oral Water Hydration to Prevent Post-Vaccination Presyncope
NCT02353390 is an interventional trial sponsored by Duke University. As of 21 Nov 2026, it is completed. It studies Presyncope and Syncope. The registry lists an enrollment of 1,820 participants at 2 sites in 1 country. The registry lists a start date of 31 Mar 2015 and a primary completion date of 30 Jun 2016.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT02353390 |
| Status | Completed |
| Study type | Interventional trial |
| Lead sponsor | Duke University |
| Enrollment | 1,820 |
| Registered sites | 2 |
| Countries | 1 |
| Conditions | Presyncope and Syncope |
| Start | 31 Mar 2015 |
| Primary completion | 30 Jun 2016 |
| Study completion | 30 Jun 2016 |
| Last update posted | 7 Jul 2016 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Alex R Kemper, MD, MPH, MS
Duke University
Principal Investigator - Elizabeth D Barnett, MD
Boston University
Principal Investigator - Theresa Harrington, MD
Centers for Disease Control and Prevention
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Boston Medical Center
Boston
- Duke University Medical Center
Durham
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT02353390
Each answer restates registry values shown on this page.
What is NCT02353390?
NCT02353390 is an interventional trial sponsored by Duke University. It studies Presyncope and Syncope.
Who leads NCT02353390?
The registry names Alex R Kemper, MD, MPH, MS (principal investigator, Duke University), Elizabeth D Barnett, MD (principal investigator, Boston University), and Theresa Harrington, MD (principal investigator, Centers for Disease Control and Prevention) as overall officials.
Where does NCT02353390 run?
The registry lists 2 sites in 1 country. Every site with a stated country is in one country: United States.
When did NCT02353390 end?
The registry lists a primary completion date of 30 Jun 2016 and a study completion date of 30 Jun 2016. The sponsor last updated the record on 7 Jul 2016.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.